Compare Danaher Corporation (DHR) vs Honest Company Inc (HNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Danaher Corporation vs Honest Company Inc — how do they compare? Danaher Corporation trades at $198.81 (market cap $140.88B), while Honest Company Inc trades at $3.95 (market cap $435.91M). The key difference: Danaher Corporation is far larger — about 323.2× Honest Company Inc's market cap, and Danaher Corporation pays a 0.8% dividend while Honest Company Inc pays none. Which is the better fit depends on your goals.
| DHR | HNST | |
|---|---|---|
Market Cap | $140.88B | $435.91M |
Sector | Health | Consumer Staples |
52-Week High | $242.05 | $4.95 |
52-Week Low | $161.91 | $2.10 |
Enterprise Value | $153.66B | $357.31M |
Dividend Yield | 0.8% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Danaher (DHR) trades at $200.16, up 0.56% today, with a bullish technical signal from moving averages and strong analyst support. The company reported Q1 2026 EPS of $2.06, beating estimates of $1.94, marking the third consecutive quarterly beat. Revenue for 2025 was $24.57 billion with a net income margin of 14.89%, though margins have compressed from prior years. Recent news includes the acquisition of Masimo and a $172.5 million legal settlement finalized in April 2026.
The outlook remains positive with a consensus price target of $211.33, implying ~5.6% upside, supported by 69% buy ratings. Key risks include margin pressure, integration challenges from acquisitions, and macroeconomic sensitivity. The stock offers a dividend yield from its $0.40 quarterly payout, with solid cash flow generation offsetting debt levels.
HNST trades at $3.90, down 2.74% today, with a bullish technical signal from moving averages. The company reported Q1 2026 EPS of $0.01, meeting expectations, while revenue trends show volatility with 2025 revenue at $371.32M. Gross margins improved to 33.89%, but net income remains negative at -$15.69M for 2025. Positive cash flow from operations of $15.12M supports liquidity, though profitability challenges persist.
Outlook is mixed: analyst consensus leans hold (50%) with 30% buy ratings, citing improved fundamentals but limited upside. Key risks include sustained negative net margins and competitive pressures in personal care. The stock's high P/E of 48.83 suggests premium valuation despite lack of profits, requiring careful risk assessment for investment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →
